Evidence map›Paper›PMID 30647813›Full record

ArticleOxidative medicine and cellular longevity2018

mTOR Modulates Methamphetamine-Induced Toxicity through Cell Clearing Systems.

Gloria Lazzeri, Francesca Biagioni, Federica Fulceri, Carla L Busceti, Maria C Scavuzzo, Chiara Ippolito, Alessandra Salvetti, Paola Lenzi, Francesco Fornai

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Bacopa Protects against Neurotoxicity Induced by MPPMolecules (Basel, Switzerland) · 2022
    Article
  12. Alterations of Mitochondrial Structure in Methamphetamine Toxicity.International journal of molecular sciences · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Targeting AOxidative medicine and cellular longevity · 2022
    Article
  17. An attempt to dissect a peripheral marker based on cell pathology in Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Gloria LazzeriDepartment of Translational Research and New Technologies in Medicine and Surgery, Human Anatomy, University of Pisa, Via Roma 55, Pisa 56126, Italy.ORCID 0000-0003-4607-098X
Francesca BiagioniI.R.C.C.S Neuromed, Via Atinense 18, Pozzilli 86077, Italy.ORCID 0000-0003-3566-4889
Federica FulceriDepartment of Clinical and Experimental Medicine, University of Pisa, Via Roma 55, Pisa 56126, Italy.ORCID 0000-0003-0790-1218
Carla L BuscetiI.R.C.C.S Neuromed, Via Atinense 18, Pozzilli 86077, Italy.ORCID 0000-0002-1417-1893
Maria C ScavuzzoDepartment of Translational Research and New Technologies in Medicine and Surgery, Human Anatomy, University of Pisa, Via Roma 55, Pisa 56126, Italy.ORCID 0000-0002-4183-9393
Chiara IppolitoDepartment of Clinical and Experimental Medicine, University of Pisa, Via Roma 55, Pisa 56126, Italy.
Alessandra SalvettiDepartment of Clinical and Experimental Medicine, University of Pisa, Via Roma 55, Pisa 56126, Italy.ORCID 0000-0002-9154-9773
Paola LenziDepartment of Translational Research and New Technologies in Medicine and Surgery, Human Anatomy, University of Pisa, Via Roma 55, Pisa 56126, Italy.ORCID 0000-0002-4734-8798
Francesco FornaiDepartment of Translational Research and New Technologies in Medicine and Surgery, Human Anatomy, University of Pisa, Via Roma 55, Pisa 56126, Italy.ORCID 0000-0002-3883-5084
University of Pisa · ITIstituto Neurologico Mediterraneo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methamphetamine (METH) is abused worldwide, and it represents a threat for public health. METH exposure induces a variety of detrimental effects. In fact, METH produces a number of oxidative species, which lead to lipid peroxidation, protein misfolding, and nuclear damage. Cell clearing pathways such as ubiquitin-proteasome (UP) and autophagy (ATG) are involved in METH-induced oxidative damage. Although these pathways were traditionally considered to operate as separate metabolic systems, recent studies demonstrate their interconnection at the functional and biochemical level. Very recently, the convergence between UP and ATG was evidenced within a single organelle named autophagoproteasome (APP), which is suppressed by mTOR activation. In the present research study, the occurrence of APP during METH toxicity was analyzed. In fact, coimmunoprecipitation indicates a binding between LC3 and P20S particles, which also recruit p62 and alpha-synuclein. The amount of METH-induced toxicity correlates with APP levels. Specific markers for ATG and UP, such as LC3 and P20S in the cytosol, and within METH-induced vacuoles, were measured at different doses and time intervals following METH administration either alone or combined with mTOR modulators. Western blotting, coimmunoprecipitation, light microscopy, confocal microscopy, plain transmission electron microscopy, and immunogold staining were used to document the effects of mTOR modulation on METH toxicity and the merging of UP with ATG markers within APPs. METH-induced cell death is prevented by mTOR inhibition, while it is worsened by mTOR activation, which correlates with the amount of autophagoproteasomes. The present data, which apply to METH toxicity, are also relevant to provide a novel insight into cell clearing pathways to counteract several kinds of oxidative damage.

Indexed as

HumansMethamphetamineTOR Serine-Threonine KinasesMethamphetamineMTOR protein, humanTOR Serine-Threonine Kinases

Identifiers

PMID30647813
PMCPMC6311854
OpenAlexW2899062420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.